Literature DB >> 17719011

Characterization and differentiation of equine umbilical cord-derived matrix cells.

Steven M Hoynowski1, Madeline M Fry, Bryn M Gardner, Matthew T Leming, Jeanell R Tucker, Linda Black, Theodore Sand, Kathy E Mitchell.   

Abstract

Stem cells are being evaluated in numerous human clinical trials and are commercially used in veterinary medicine to treat horses and dogs. Stem cell differentiation, homing to disease sites, growth and cytokine factor modulation, and low antigenicity contribute to their therapeutic success. Bone marrow and adipose tissue are the two most common sources of adult-derived stem cells in animals. We report on the existence of an alternative source of primitive, multipotent stem cells from the equine umbilical cord cellular matrix (Wharton's jelly). Equine umbilical cord matrix (EUCM) cells can be cultured, cryogenically preserved, and differentiated into osteo-, adipo-, chondrogenic, and neuronal cell lineages. These results identify a source of stem cells that can be non-invasively collected at birth and stored for future use in that horse or used as donor cells for treating unrelated horses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719011     DOI: 10.1016/j.bbrc.2007.07.182

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

Review 1.  Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.

Authors:  Jennifer M Ryan; Allison R Pettit; Pascale V Guillot; Jerry K Y Chan; Nicholas M Fisk
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

2.  Cultured buffalo umbilical cord matrix cells exhibit characteristics of multipotent mesenchymal stem cells.

Authors:  Jarnail Singh; Anita Mann; D Kumar; J S Duhan; P S Yadav
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-25       Impact factor: 2.416

3.  Size-sieved subpopulations of mesenchymal stem cells from intervascular and perivascular equine umbilical cord matrix.

Authors:  B Corradetti; A Lange-Consiglio; M Barucca; F Cremonesi; D Bizzaro
Journal:  Cell Prolif       Date:  2011-06-06       Impact factor: 6.831

4.  Further insights into the characterization of equine adipose tissue-derived mesenchymal stem cells.

Authors:  Oksana Raabe; Katja Shell; Antonia Würtz; Christine Maria Reich; Sabine Wenisch; Stefan Arnhold
Journal:  Vet Res Commun       Date:  2011-05-26       Impact factor: 2.459

Review 5.  The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.

Authors:  Ariff Bongso; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

6.  Tenogenic induction of equine mesenchymal stem cells by means of growth factors and low-level laser technology.

Authors:  Chiara Gomiero; Giulia Bertolutti; Tiziana Martinello; Nathalie Van Bruaene; Sarah Y Broeckx; Marco Patruno; Jan H Spaas
Journal:  Vet Res Commun       Date:  2016-01-13       Impact factor: 2.459

7.  Immunophenotypic characterization and tenogenic differentiation of mesenchymal stromal cells isolated from equine umbilical cord blood.

Authors:  Niharika Mohanty; Baldev R Gulati; Rajesh Kumar; Sandeep Gera; Pawan Kumar; Rajesh K Somasundaram; Sandeep Kumar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-01-11       Impact factor: 2.416

Review 8.  Advances in translational orthopaedic research with species-specific multipotent mesenchymal stromal cells derived from the umbilical cord.

Authors:  Melina Ramallo; Irene Carreras-Sánchez; Alba López-Fernández; Roberto Vélez; Màrius Aguirre; Sara Feldman; Joaquim Vives
Journal:  Histol Histopathol       Date:  2020-09-11       Impact factor: 2.303

9.  Non-random tissue distribution of human naïve umbilical cord matrix stem cells.

Authors:  Dharmendra Kumar Maurya; Chiyo Doi; Marla Pyle; Raja Shekar Rachakatla; Duane Davis; Masaaki Tamura; Deryl Troyer
Journal:  World J Stem Cells       Date:  2011-04-26       Impact factor: 5.326

Review 10.  Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?

Authors:  Jan H Spaas; Deborah J Guest; Gerlinde R Van de Walle
Journal:  Sports Med       Date:  2012-10-01       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.